Kaplan-Meier time to tumor progression (TTP) of patients treated with FOLFOX/Bevacizumab

<p><b>Copyright information:</b></p><p>Taken from "Front-line Bevacizumab in combination with Oxaliplatin, Leucovorin and 5-Fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study"</p><p>BMC Cancer 2007;7():91-91.</p><p>Published online 30 May 2007</p><p>PMCID:PMC1894803.</p><p></p